These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


218 related items for PubMed ID: 24949992

  • 1. Preparation, characterization, cytotoxicity, and genotoxicity evaluations of thiolated- and s-nitrosated superparamagnetic iron oxide nanoparticles: implications for cancer treatment.
    Seabra AB, Pasquôto T, Ferrarini AC, Santos Mda C, Haddad PS, de Lima R.
    Chem Res Toxicol; 2014 Jul 21; 27(7):1207-18. PubMed ID: 24949992
    [Abstract] [Full Text] [Related]

  • 2. Nitric oxide donor superparamagnetic iron oxide nanoparticles.
    Molina MM, Seabra AB, de Oliveira MG, Itri R, Haddad PS.
    Mater Sci Eng C Mater Biol Appl; 2013 Mar 01; 33(2):746-51. PubMed ID: 25427482
    [Abstract] [Full Text] [Related]

  • 3. Long term biotransformation and toxicity of dimercaptosuccinic acid-coated magnetic nanoparticles support their use in biomedical applications.
    Mejías R, Gutiérrez L, Salas G, Pérez-Yagüe S, Zotes TM, Lázaro FJ, Morales MP, Barber DF.
    J Control Release; 2013 Oct 28; 171(2):225-33. PubMed ID: 23906866
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Characterization of interaction of magnetic nanoparticles with breast cancer cells.
    Calero M, Chiappi M, Lazaro-Carrillo A, Rodríguez MJ, Chichón FJ, Crosbie-Staunton K, Prina-Mello A, Volkov Y, Villanueva A, Carrascosa JL.
    J Nanobiotechnology; 2015 Feb 26; 13():16. PubMed ID: 25880445
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Subtle cytotoxicity and genotoxicity differences in superparamagnetic iron oxide nanoparticles coated with various functional groups.
    Hong SC, Lee JH, Lee J, Kim HY, Park JY, Cho J, Lee J, Han DW.
    Int J Nanomedicine; 2011 Feb 26; 6():3219-31. PubMed ID: 22238510
    [Abstract] [Full Text] [Related]

  • 8. Preparation and characterization of magnetic gold nanoparticles to be used as doxorubicin nanocarriers.
    Elbialy NS, Fathy MM, Khalil WM.
    Phys Med; 2014 Nov 26; 30(7):843-8. PubMed ID: 24950615
    [Abstract] [Full Text] [Related]

  • 9. DMSA-Coated Iron Oxide Nanoparticles Greatly Affect the Expression of Genes Coding Cysteine-Rich Proteins by Their DMSA Coating.
    Zhang L, Wang X, Zou J, Liu Y, Wang J.
    Chem Res Toxicol; 2015 Oct 19; 28(10):1961-74. PubMed ID: 26378955
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Labeling mesenchymal cells with DMSA-coated gold and iron oxide nanoparticles: assessment of biocompatibility and potential applications.
    Silva LH, da Silva JR, Ferreira GA, Silva RC, Lima EC, Azevedo RB, Oliveira DM.
    J Nanobiotechnology; 2016 Jul 18; 14(1):59. PubMed ID: 27431051
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.